Home » Topics » BioWorld Science

BioWorld Science
RSS

New antiasthma compound reported at Japanese congress

Dec. 1, 1997

Novel retinoids from Roche

Dec. 1, 1997

rhIL-10 improves quality of life in patients with Crohn's disease

Dec. 1, 1997

AHP describes new compounds with tissue-selective estrogenic and antiestrogenic effects

Dec. 1, 1997

Triangle Pharmaceuticals: Q3 1997 highlights

Dec. 1, 1997

Axis receives grant for plant-based vaccine development; phase I trials to begin in 1999

Dec. 1, 1997

Ibex announces changes in product development schedule

Dec. 1, 1997

Genetronics and Abbott enter drug supply alliance

Dec. 1, 1997

Ansan and Discovery Laboratories merge

Dec. 1, 1997

Genentech: Q3 1997 highlights

Dec. 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
IMV-101 shows promise for B-cell malignancies
BioWorld Science
IMV-101 is a new CAR T-cell therapy targeting CD19 developed by Suzhou Immunofoco Biotechnology Co. Ltd. for the potential treatment of B-cell malignancies and...